Amicus Therapeutics, Inc. Announces Data Presentations and Posters at Upcoming Scientific Meetings

Published: Oct 16, 2012

CRANBURY, N.J., Oct. 16, 2012 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced that an oral presentation and 3 posters related to its investigational pharmacological chaperones will be included at two upcoming scientific meetings.

Back to news